Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1168.20% is 3139% below its 5-year average of -36.07%, near the high end of its 5-year range (-9544.45%–0.00%).
32.44% above its 12-month average of -1729.20%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -504.79%.
NET PROFIT MARGIN
-1168.20%
NET PROFIT MARGIN AVG TTM
-1729.20%
NET PROFIT MARGIN AVG 3Y
-670.64%
NET PROFIT MARGIN AVG 5Y
-36.07%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
0.00%
NET PROFIT MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
+32.44%
CURRENT VS 3Y AVG
-74.19%
CURRENT VS 5Y AVG
-3138.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 711 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MediciNova, Inc.
Market Cap
$82.73M
Net Profit Margin
-1168.20%
TTM Avg
-1729.20%
3Y Avg
-670.64%
5Y Avg
-36.07%
Market Cap
$83.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.53M
Net Profit Margin
57.57%
TTM Avg
-58.69%
3Y Avg
-51.95%
5Y Avg
-56.60%
Market Cap
$83.48M
Net Profit Margin
-648.32%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.78M
Net Profit Margin
-7884.06%
TTM Avg
-7191.86%
3Y Avg
-8225.67%
5Y Avg
-7676.39%
Market Cap
$85.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$80.47M
Net Profit Margin
-430.43%
TTM Avg
-446.97%
3Y Avg
-347.08%
5Y Avg
-386.84%
Market Cap
$85.13M
Net Profit Margin
-4560.82%
TTM Avg
-1001.79%
3Y Avg
-692.03%
5Y Avg
-1554.36%
Market Cap
$80.04M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediciNova, Inc. (MNOV) | $82.73M | -1168.20% | -1729.20% | -670.64% | -36.07% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| LENSAR Inc (LNSR)vs › | $82.53M | 57.57% | -58.69% | -51.95% | -56.60% |
| Citius Oncology, Inc. (CTOR)vs › | $83.48M | -648.32% | 0.00% | 0.00% | 0.00% |
| Cardiff Oncology, Inc. (CRDF)vs › | $84.78M | -7884.06% | -7191.86% | -8225.67% | -7676.39% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nutriband Inc. (NTRB)vs › | $80.47M | -430.43% | -446.97% | -347.08% | -386.84% |
| Humacyte, Inc. (HUMA)vs › | $85.13M | -4560.82% | -1001.79% | -692.03% | -1554.36% |
| Pulmonx Corporation (LUNG)vs › | $80.04M | -55.03% | -63.48% | -81.34% | -87.39% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $85.55M | 0.00% | 0.00% | 0.00% | -72272.26% |
Operating Margin
-3242.5%
Net Profit Margin
-1168.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -504.79% |
| 2026-03-31 | -1383.14% |
| 2025-12-31 | -1846.78% |
| 2025-09-30 | -2473.56% |
| 2025-06-30 | -2437.75% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -72.31% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | -9544.45% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | -4.69% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 56.89% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | -74271.23% |
| 2012-12-31 | -7159.59% |
| 2012-09-30 | -2839.07% |
| 2012-06-30 | -462.16% |
| 2012-03-31 | -2022.88% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | -29.67% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 12876.30% |
| 2006-09-30 | -8762.46% |
| 2006-06-30 | -10848.49% |
| 2006-03-31 | -4396.10% |
| 2005-12-31 | -988.41% |
| 2005-09-30 | -15711.15% |
| 2005-06-30 | -22490.93% |
| 2005-03-31 | -260165.11% |
| 2004-12-31 | -2881.48% |
| 2004-09-30 | -10579.74% |
| 2004-06-30 | -34306.54% |
| 2004-03-31 | -5192.33% |
| 2001-09-30 | 0.00% |